恢复瘤抗原性激活了"旁观者"T细胞免疫循环
Yifan Yang1, Qiumin Yu1, Haoyu Zhang1
1Jiangsu Key Laboratory of Draggability of Biopharmaceuticals and State, Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, China.
这项研究引入了一种新的细胞内输送系统,ASCP,以重编程瘤细胞. 这一策略将现有的病毒特异性T细胞 (TBYS) 转向向癌症,提高免疫疗法的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 瘤特异性T细胞对免疫至关重要,但在瘤微环境 (TME) 中经常耗尽.
- 在TME中含有丰富的病毒特异性"旁观者"T细胞 (TBYS),具有抗瘤潜力.
- 目前癌症免疫疗法的有限疗效需要新的策略.
研究的目的:
- 开发一种用于重定向先前存在的TBYS细胞以识别和消除瘤细胞的方法.
- 通过利用TBYS细胞的功能记忆特征来增强抗瘤免疫力.
- 研究细胞内传递系统在癌症免疫治疗中的潜力.
主要方法:
- 设计了一个细胞内传递系统 (ASCP),编码一个TBYS表位,以重定向T细胞特异性.
- 使用ASCP-抗原来恢复瘤细胞的抗原性,并诱导表皮层扩散.
- 将非自然氨基酸 (p-nitrophenylalanine,NiraTh) 纳入MHC-II表位,以刺激CD4+T细胞免疫力.
主要成果:
- ASCP有效地重定向TBYS细胞,导致在临床前模型中显著的瘤抑制.
- 该策略恢复了瘤细胞的抗原性,并通过表位细胞扩散诱导了更广泛的T细胞反应.
- 通过含有NiraTh的MHC-II表位体刺激CD4+T细胞免疫力,有助于CD8+T细胞瘤清除.
结论:
- 通过ASCP介导的瘤抗原重编程是癌症免疫治疗的一个有前途的策略.
- 这种方法可以利用先前存在的TBYS细胞,特别是在先前病毒感染的个体中.
- 这些发现为增强T细胞介导的抗瘤反应提供了新的见解.
更多相关视频
10:44A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
Published on: August 9, 2019
07:45Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
相关概念视频
Tumor Immunotherapy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cell-mediated Immune Responses
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
